Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · IEX Real-Time Price · USD
71.25
+1.36 (1.94%)
May 1, 2024, 12:52 PM EDT - Market open

Ligand Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
58
Market Cap
1.28B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022196.25M-45.30M-18.75%
Dec 31, 2021241.54M77.98M47.68%
Dec 31, 2020163.56M43.28M35.98%
Dec 31, 2019120.28M-131.17M-52.17%
Dec 31, 2018251.45M110.35M78.21%
Dec 31, 2017141.10M32.13M29.48%
Dec 31, 2016108.97M37.06M51.53%
Dec 31, 201571.91M7.38M11.43%
Dec 31, 201464.54M15.57M31.78%
Dec 31, 201348.97M17.59M56.02%
Dec 31, 201231.39M1.35M4.50%
Dec 31, 201130.04M6.50M27.61%
Dec 31, 201023.54M-15.40M-39.55%
Dec 31, 200938.94M11.63M42.56%
Dec 31, 200827.32M14.42M111.84%
Dec 31, 200712.89M8.92M224.21%
Dec 31, 20063.98M-6.24M-61.07%
Dec 31, 200510.22M-101.90M-90.89%
Dec 31, 2004112.11M30.99M38.21%
Dec 31, 200381.12M9.35M13.03%
Dec 31, 200271.77M-4.57M-5.99%
Dec 31, 200176.34M28.23M58.68%
Dec 31, 200048.11M7.22M17.64%
Dec 31, 199940.90M23.22M131.40%
Dec 31, 199817.67M-34.03M-65.82%
Dec 31, 199751.70M14.86M40.33%
Dec 31, 199636.84M12.33M50.28%
Dec 31, 199524.52M11.21M84.21%
Dec 31, 199413.31M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Brookdale Senior Living 3.02B
Omnicell 1.15B
Pacira BioSciences 674.98M
NovoCure 509.34M
Ironwood Pharmaceuticals 442.74M
Kiniksa Pharmaceuticals 301.77M
Xencor 168.34M
4D Molecular Therapeutics 20.72M
Revenue Rankings